Clival giant cell tumor - A rare case report and review of literature with respect to current line of management

Mohana Rao Patibandla; Amit Kumar Thotakura; Marabathina Nageswara Rao; Gokul Chowdary Addagada; Manisha Chowdary Nukavarapu; Manas Kumar Panigrahi; Shantiveer Uppin; Sundaram Challa; Srinivas Dandamudi

doi:10.4103/1793-5482.145112

An Official publication of The Asian Congress of Neurological Surgeons (AsianCNS)

Users Online: 402

CASE REPORT

Year : 2017 | Volume : 12 | Issue : 1 | Page : 78-81

Clival giant cell tumor - A rare case report and review of literature with respect to current line of management

Mohana Rao Patibandla¹, Amit Kumar Thotakura¹, Marabathina Nageswara Rao², Gokul Chowdary Addagada³, Manisha Chowdary Nukavarapu³, Manas Kumar Panigrahi⁴, Shantiveer Uppin⁵, Sundaram Challa⁵, Srinivas Dandamudi⁶
¹ Department of Neurosurgery, Nizam's Institute of Medical Sciences, Hyderabad, India
² Department of Neurosurgery, NRI Medical College, Mangalagiri, Guntur, Andhra Pradesh, India
³ Guntur Medical College, Guntur, Andhra Pradesh, India
⁴ Krishna Institute of Medical Sciences, Secunderabad, Telangana, India
⁵ Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, India
⁶ Department of Radiology, NRI Medical College, Mangalagiri, Guntur, Andhra Pradesh, India

Correspondence Address:
Amit Kumar Thotakura
Department of Neurosurgery, NRI Medical College, Mangalagiri, Guntur - 522 503, Andhra Pradesh
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/1793-5482.145112

Giant-cell tumor (GCT) involving the skull base is rare. Sphenoid bone is the most commonly involved bone followed by petrous temporal bone. Histopathology and radiological features of these lesions are similar to GCT involving bone elsewhere. Unlike other sites, skull base is not an ideal site for the radical surgery. Hence adjuvant treatment has pivotal role. Radiation therapy with intensity-modulated radiation therapy, stereotactic radiosurgery or chemotherapy with adriamycin are promising as described in some case reports. Bisphosphonates showed good control in local recurrence. In vitro studies with Zolendronate loaded bone cement and phase 2 trials of Denosumab showed hopeful results, may be useful in future.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	3346

Printed	69

Emailed	0

PDF Downloaded	279

Comments	[Add]

Cited by others	2